Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kalinox Sedation in Primary Care Dental Centers
NCT00643838Phase 3Completed
- Sponsor
- Air Liquide
- Start
- Dec 2007
- Primary completion
- Jul 2008
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of nitrous oxide + oxygen in Dental anxiety and Dental phobia, sponsored by Air Liquide. Primary endpoint: Pain measurement by Visual Analog Scale and Face Pain Scale. Started Dec 2007; status: completed.
02
Drugs
nitrous oxide + oxygen
03
Conditions
Dental anxietyDental phobia
Beyond the preview
Go deeper on NCT00643838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00643838.